| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1882462 | Radiation Physics and Chemistry | 2014 | 4 Pages |
In this work, synchrotron X-ray powder diffraction data allowed for a successful indexing of LASSBio-1515 compound, candidate to analgesic and anti-inflammatory activity. X-ray powder diffraction data collected in transmission and high-throughput geometries were used to analyze this compound. The X-ray wavelength of the synchrotron radiation used in this study was determined to be λ=1.55054 Å. LASSBio-1515 was found to be monoclinic with space group P21/c and unit cell parameters a=11.26255(16) Å, b=12.59785(16) Å, c=8.8540(1) Å, β=90.5972(7)° and V=1256.17(3) Å3.
► LASSBio-1515 is a new N-acylhydrozone derivative compound. ► Molecular simplification strategy used in the rational planning of LASSBio-1515. ► Synchrotron XRPD data allowed for a successful indexing of LASSBio-1515 compound. ► This was indexed as having a monoclinic system (P21/c).
